亚洲 · 综合新闻 · The Korea Herald
Samsung Bioepis secures 10-year biosimilar supply deal in Brazil
Samsung Bioepis said Tuesday it has secured a 10-year deal to exclusively supply its rare disease biosimilar SB12 to Brazil's public health system, strengthenin ...
在 The Korea Herald 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.koreaherald.com)





